Philips Recalled CPAP/Bi-Level PAP Litigation Update: Federal Cases Centralized in MDL in Western District of Pennsylvania

Philips CPAP and BiPAP Recall
Philips Recalled CPAP/Bi-Level PAP Litigation Update: Federal Cases Centralized in MDL in Western District of Pennsylvania

On October 8, 2021, the Judicial Panel on Multidistrict Litigation (“JPML”) created a new MDL (“multidistrict litigation”) for federal lawsuits for individuals who have suffered due to Philips’ recalled Continuous Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (Bi-Level PAP), and mechanical ventilator devices, which contain polyester-based polyurethane (PE-PUR) sound abatement foam that may degrade…

Read More

UPDATE ON XARELTO INTERNAL BLEEDING LAWSUITS

Pharmaceutical litigation

The Xarelto (rivaroxaban) litigation involves numerous lawsuits from across the country alleging that individuals taking Xarelto suffered severe or fatal bleeding or other injuries. They further allege that Bayer and related companies did not adequately warn prescribing physicians or consumers of the risks associated with Xarelto, including the potential for severe or fatal bleeding and…

Read More